Our funding in numbers.

The Boehringer Ingelheim Stiftung fulfils its statutory purpose by funding excellent basic research in medicine, biology, and chemistry.

The foundation’s Germany-wide funding programmes Exploration Grants, Plus 3, and Rise up! offer outstanding basic scientists the necessary freedom to realise their scientific potential and to test new ideas during critical stages of their careers. The foundation also supports scientific conferences around the world, with the particular aim of promoting dialogue between different generations of scientists.

The foundation awards the internationally renowned Heinrich Wieland Prize to honour distinguished scientists from around the world for their ground-breaking research. With the Boehringer Ingelheim Prize, it honours outstanding early-career researchers in the Rhine-Main region. The foundation also endows dissertation prizes, which the University of Mainz presents to excellent PhD students.

As a recognised charitable organisation, the Boehringer Ingelheim Stiftung is not subject to corporate and trade taxes (current notice of tax exemption issued by the Bingen-Alzey tax office on 15 May 2025, for 2021 to 2023, tax ID number 08/667/10470). The annual financial statement of the Boehringer Ingelheim Stiftung is audited by Rödl Audit GmbH Wirtschaftsprüfungsgesellschaft based on the Generally Accepted Standards for the Review of Financial Statements (IDW AuS 900).

Expenditures of the Boehringer Ingelheim Stiftung 2025

In 2025, total expenditures of the Boehringer Ingelheim Stiftung amounted to 30.7 million EUR. Hereof, the promotion of science accounted for 29.6 million EUR (thereof approx. 23.5 million EUR for funding initiatives, approx. 5.7 million EUR for ongoing funding programmes and approx. 0.4 million EUR for scientific awards). Its administration costs amounted to about 1.1 million EUR.